Primary angle closure glaucoma Primary angle closure glaucoma
Conditions
Interventions
iStent inject with cataract surgery
Sponsors
Hirooka Kazuyuki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Patients with primary angle closure glaucoma who are 18 years of age or older at the time of consent 2 Patients who can give informed consent to participate in this study 3 Patients who are able to come to the hospital for 6 months after the surgery.
Exclusion criteria
Exclusion criteria: 1 Patients complicated by phacodonesis or zonular weakness 2 Patients with anterior synechiae exceeding 25% or with anterior synechiae on the nasal side 3 Patients who have difficulty in obtaining cooperation for postoperative gonioscopy 4 Patients with an MD value of less than -12 dB on a static visual field test (Humphrey 24-2) 5 Patients with a preoperative intraocular pressure of 25 mmHg or more 6 Corneal endothelial cell density less than 1,500 cells/mm2 7 Patients with metal allergy 8 Patients with a history of glaucoma surgery in the subject eye 9 Pregnant and lactating women, women who may be pregnant, or women who wish to have a baby. 10 The investigator and the research subject have a relationship as faculty member and student 11 Any other person who is deemed inappropriate by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraocular pressure 6 months after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 success rate: success is defined as IOP of 15 mmHg or less with IOP reduction of 20% or more (criterion 1) and IOP of 18 mmHg or less with IOP reduction of 20% or more (criterion 2). 2 The number and rate of adverse events | — |
Contacts
Public ContactKazuyuki Hirooka
Hiroshima University Hospital
Outcome results
None listed